Epidermolysis bullosa – Basic Information

Go back

Epidermolysis bullosa is a rare genetic condition that causes the skin to become incredibly fragile, tearing and blistering at the slightest touch. This condition affects every aspect of daily life, from eating and walking to simply getting dressed, as even minor friction can create painful wounds that may take weeks to heal.

What is Epidermolysis Bullosa?

Epidermolysis bullosa, often called EB, refers to a group of inherited skin disorders where the skin lacks the strength to withstand everyday contact. The name comes from medical terms meaning “skin” and “blister,” which accurately describes the main problem people with this condition face. The skin of someone with EB is so delicate that it has been compared to butterfly wings, which is why children with this condition are sometimes called “butterfly children.”

The condition occurs because certain proteins that normally hold the layers of skin together are either missing or not working properly. Without these proteins acting as anchors, the top layer of skin (called the epidermis) and the lower layer (called the dermis) cannot stay attached to each other. When these layers separate, blisters and open wounds form. These wounds are not only painful but also prone to infection and can leave significant scarring.

There are four main types of EB, each affecting different layers of the skin. EB simplex is the most common form and causes blisters in the outer layer of skin. Junctional EB affects the space where the outer and inner skin layers meet. Dystrophic EB causes deeper blistering in the lower layer of skin, often leaving scars. Finally, Kindler syndrome is very rare and can cause blisters in multiple skin layers at once. The severity of symptoms can range from mild, with blisters appearing only on hands and feet, to severe, with blistering affecting the entire body including internal organs.

⚠️ Important
EB is not contagious and cannot be spread from person to person through touch or any other means. It is caused by genetic mutations that are present from birth. If you see someone with visible wounds or bandages related to EB, there is no risk of catching the condition from them.

How Common is Epidermolysis Bullosa?

Epidermolysis bullosa is considered a rare disease. In the United States, approximately 1 in every 50,000 babies is born with some form of EB. This means roughly 200 children are born with the condition each year in the United States alone. Worldwide, about half a million people are estimated to live with EB. The condition affects people of all races, ethnic backgrounds, and genders equally. No particular group is more or less likely to be born with EB.

Because EB is so rare, many people, including some healthcare providers, may never encounter a case during their careers. This rarity can make diagnosis and treatment challenging, especially in areas without specialized medical centers. Families affected by EB often need to travel long distances to find doctors with experience treating the condition. The rarity also means that research funding and clinical trials are limited compared to more common conditions, though progress continues to be made in understanding and treating EB.

What Causes Epidermolysis Bullosa?

Epidermolysis bullosa is caused by mutations in genes that provide instructions for making proteins essential to skin structure. Scientists have identified at least 18 different genes that, when altered, can lead to EB. These genes normally produce proteins such as collagen VII, keratin 5 or 14, and laminin-332, which work like biological glue to keep skin layers attached to each other.

When these genes contain mutations, the proteins they produce are either absent, reduced in quantity, or malformed and unable to function properly. Without adequate amounts of functional protein, the skin cannot maintain its structural integrity. The specific gene affected and the nature of the mutation determine which type of EB a person develops and how severe their symptoms will be.

The condition is inherited, meaning it passes from parents to children through genes. In some forms of EB, inheriting one mutated gene from just one parent is enough to cause the disease. These cases follow what is called an autosomal dominant inheritance pattern. In other forms, a child must inherit mutated genes from both parents to develop EB. This is called autosomal recessive inheritance. In recessive forms, both parents are carriers of the mutation but typically do not have symptoms themselves because they also have one normal copy of the gene.

Occasionally, EB can occur due to a new mutation that happens spontaneously, meaning neither parent carried the mutated gene. These cases can be particularly surprising for families with no history of the condition. Genetic testing can help identify the specific mutation involved, which is useful for understanding the type of EB, predicting its course, and providing information for family planning decisions.

Who is at Risk?

The primary risk factor for developing EB is having parents who carry or have the genetic mutations associated with the condition. If one or both parents have EB or carry the gene mutation, there is a risk their children will inherit the condition. The specific risk depends on the inheritance pattern of the type of EB involved.

For autosomal dominant types, if one parent has EB, each child has a 50 percent chance of inheriting the condition. For autosomal recessive types, if both parents are carriers but unaffected, each child has a 25 percent chance of developing EB, a 50 percent chance of being a carrier like the parents, and a 25 percent chance of neither having the condition nor being a carrier.

Families with a history of EB in previous generations should consider genetic counseling if they are planning to have children. Genetic counselors can explain the risks, discuss testing options, and help families understand what a diagnosis might mean. For couples at risk, prenatal testing is available as early as the 11th week of pregnancy. Tests such as amniocentesis or chorionic villus sampling can determine whether a developing baby has inherited the genetic mutations that cause EB.

It is important to note that EB cannot be prevented through lifestyle changes, diet, or environmental modifications because it is entirely genetic in origin. The mutations that cause EB are present from conception and cannot be acquired later in life through illness, injury, or exposure to toxins.

Symptoms of Epidermolysis Bullosa

The hallmark symptom of epidermolysis bullosa is skin that blisters extremely easily. These blisters typically appear in response to minor trauma, friction, heat, or even rubbing. In some cases, blisters form with no apparent cause at all. The location, frequency, and severity of blistering depend on the type of EB a person has.

In mild forms of EB, blisters may primarily affect the hands and feet, appearing after walking, playing, or holding objects. The palms and soles may develop thick, hardened areas of skin called calluses as the body attempts to protect these frequently blistered areas. Some people with mild EB find that their symptoms improve as they get older and learn to avoid activities that trigger blistering.

More severe forms of EB can cause widespread blistering across the entire body. Blisters may appear on the arms, legs, back, and torso. They can also form inside the body, affecting the mouth, throat, esophagus, and other internal organs. Blisters in the mouth make eating painful and difficult. When the esophagus is affected, swallowing becomes challenging, and repeated blistering can lead to narrowing of this tube over time, making it even harder to get food down to the stomach.

Other common symptoms include fingernails and toenails that are thickened, deformed, or fail to grow properly. Some people develop small white bumps on their skin called milia, which are tiny cysts formed when dead skin cells get trapped beneath the surface. Hair loss may occur, particularly on the scalp, when repeated blistering and scarring damage hair follicles. Dental problems are frequent in some types of EB because blistering affects the mouth, and the enamel on teeth may not form properly.

Children with EB often have difficulty gaining weight and growing at an expected rate. This happens partly because eating is painful when the mouth and throat have blisters, and partly because the body uses enormous amounts of energy trying to heal the constant wounds. Anemia, a condition where the blood lacks adequate red blood cells, is common because chronic wounds lead to slow but persistent blood loss and because the body has trouble keeping up with the demand for new blood cells.

As time goes on, repeated blistering and healing can cause severe scarring. In dystrophic forms of EB, scars can cause fingers and toes to fuse together, creating a mitten-like appearance. Joints may become stiff and difficult to move. The eyes can be affected by blisters on the cornea, potentially leading to vision problems. In the most severe cases, particularly with certain types of junctional EB, extensive blistering in infancy can lead to life-threatening complications including severe infections, dehydration, malnutrition, and breathing difficulties.

⚠️ Important
People with certain severe forms of EB, particularly dystrophic EB, face a significantly increased risk of developing an aggressive type of skin cancer called squamous cell carcinoma, often at a young age. Regular skin monitoring by healthcare providers is essential for early detection and treatment of any suspicious areas.

Can Epidermolysis Bullosa be Prevented?

Because epidermolysis bullosa is a genetic condition present from birth, there is currently no way to prevent it from occurring in someone who has inherited the causative mutations. However, families with a history of EB can take steps to make informed decisions about family planning.

Genetic counseling is recommended for anyone with a family history of EB who is considering having children. A genetic counselor can analyze family history, explain the likelihood of passing EB to children, and discuss available options. For couples at risk, prenatal testing can detect EB in a developing fetus, allowing families to prepare for the specialized care a baby with EB will need or to make other decisions based on their values and circumstances.

For individuals living with EB, prevention efforts focus on reducing the number and severity of blisters that form. This involves learning to minimize friction and trauma to the skin in all daily activities. Simple measures can make a significant difference. Wearing soft, loose-fitting clothing made from natural fabrics like cotton helps reduce rubbing against the skin. Shoes should fit properly without tight spots or rough seams that could rub. Keeping the body cool is important because sweating can irritate fragile skin.

Parents of children with EB need to modify how they handle their child, avoiding pulling or tugging on the skin. Special techniques for changing diapers, dressing, and bathing are necessary. As children grow, they must learn to avoid activities that are likely to cause blistering while still maintaining as normal a life as possible. Swimming is often a good activity because the water supports the body without creating friction.

Preventing complications from blisters that do form is equally important. Learning proper wound care techniques helps prevent infections, which can make EB much worse. Good nutrition supports wound healing and overall health, even though eating may be difficult. Physical therapy helps maintain flexibility and prevent joint problems from scarring. Regular dental care prevents tooth decay, which is more common in people with EB. For those with types of EB that increase cancer risk, vigilant skin monitoring and protection from sun exposure are essential preventive measures.

How Epidermolysis Bullosa Affects the Body

At the cellular level, epidermolysis bullosa disrupts the normal structure and function of skin. Healthy skin consists of several layers held together by specialized proteins that act as molecular anchors and glue. The outermost layer, the epidermis, sits on top of a basement membrane zone, which in turn rests on the dermis below. This basement membrane zone contains numerous proteins including collagens, keratins, and laminins that link the layers together.

In EB, mutations prevent the normal production or function of one or more of these crucial proteins. When the protein anchors are absent or defective, the mechanical strength of skin is dramatically reduced. Forces that healthy skin easily withstands—such as gentle rubbing, minor bumps, or even changes in temperature—can cause the skin layers to separate in someone with EB. When this separation occurs, fluid fills the space between the layers, creating a blister.

The body responds to these blisters as it would to any wound, triggering an inflammatory response and beginning the healing process. However, in EB, healing is often impaired. In some types, particularly junctional EB, the very proteins needed for skin cells to migrate and close wounds are defective, making healing slow and incomplete. Chronic inflammation from repeated blistering can lead to progressive scarring and tissue damage.

When blisters form inside the mouth or esophagus, healing creates scar tissue that can narrow these passages over time. This narrowing, called stricture, makes swallowing progressively more difficult. In the esophagus, repeated cycles of blistering and scarring can eventually make it nearly impossible to swallow solid food, requiring surgical procedures to widen the passage or even placement of a feeding tube to deliver nutrition directly to the stomach.

The constant wound healing process places enormous metabolic demands on the body. The body needs extra energy, protein, vitamins, and minerals to continuously repair damaged tissue and produce new skin. Children with extensive blistering may require 150 percent or more of the normal caloric intake for their age just to maintain their weight. The chronic inflammation and blood loss from wounds contribute to anemia and fatigue.

In severe forms of dystrophic EB, repeated blistering and scarring can cause permanent deformities. As scars tighten over time, they can pull fingers together until they fuse, creating what doctors call “mitten hands.” Similar scarring around other joints can limit movement and make simple tasks like bending the elbow or knee difficult. The skin may lose its elastic quality entirely in heavily scarred areas, becoming rigid and tight.

Over many years, the chronic inflammation and repeated cycles of wounding and healing in dystrophic EB can trigger changes in skin cells that lead to cancer. Squamous cell carcinomas arising in people with EB tend to be particularly aggressive and occur at much younger ages than skin cancers in the general population, sometimes appearing in teenagers or young adults rather than in older age.

Ongoing Clinical Trials on Epidermolysis bullosa

  • Study on the Effects of TCP-25 Gel for Wound Healing in Patients with Epidermolysis Bullosa

    Recruiting

    Investigated diseases:
    France Greece Italy Spain Sweden
  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    1 1
    Investigated diseases:
    France
  • Study on the Effects of Deucravacitinib for Adults with Inflammatory Skin Conditions (Epidermolysis Bullosa Simplex and Congenital Ichthyoses)

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Austria Croatia Denmark France Germany Greece +6
  • Study on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa

    Not recruiting

    1 1
    Investigated diseases:
    Czechia

References

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/symptoms-causes/syc-20361062

https://my.clevelandclinic.org/health/diseases/17792-epidermolysis-bullosa

https://www.nhs.uk/conditions/epidermolysis-bullosa/

https://en.wikipedia.org/wiki/Epidermolysis_bullosa

https://www.debra.org/about-eb/understanding-epidermolysis-bullosa-eb

https://www.ncbi.nlm.nih.gov/books/NBK599531/

https://www.chop.edu/conditions-diseases/epidermolysis-bullosa

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/diagnosis-treatment/drc-20361146

https://www.aad.org/public/diseases/a-z/epidermolysis-bullosa-treatment

https://www.nhs.uk/conditions/epidermolysis-bullosa/treatment/

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.debra.org/about-eb/approved-treatments-eb

https://www.childrenscolorado.org/advances-answers/recent-articles/epidermolysis-bullosa-treatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6900197/

https://emedicine.medscape.com/article/1062939-treatment

https://www.aad.org/public/diseases/a-z/epidermolysis-bullosa-self-care

https://www.debra.org/more-eb-guides/daily-living

https://pmc.ncbi.nlm.nih.gov/articles/PMC10921121/

https://my.clevelandclinic.org/health/diseases/17792-epidermolysis-bullosa

https://epidermolysisbullosanews.com/living-epidermolysis-bullosa/

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/diagnosis-treatment/drc-20361146

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.almondcare.co.uk/a-guide-to-caring-for-those-with-epidermolysis-bullosa/

https://www.news-medical.net/health/Treatment-and-Tips-for-Epidermolysis-Bullosa.aspx

FAQ

Is epidermolysis bullosa contagious?

No, epidermolysis bullosa is not contagious at all. It is a genetic condition caused by inherited mutations in genes that affect skin structure. You cannot catch EB from touching someone who has it, and people with EB pose no infection risk to others around them.

Can children with EB go to school?

Yes, many children with EB attend regular schools, though accommodations are often necessary. Teachers and classmates may need education about the condition, special care must be taken to avoid rough play or contact sports, and the school may need to make adjustments for wound care and comfortable seating. The extent of participation depends on the severity of the individual’s condition.

Does epidermolysis bullosa get better with age?

For some people with mild forms of EB, particularly EB simplex, symptoms may improve somewhat as they grow older. However, more severe forms often remain challenging throughout life. Some types may even become more complicated over time due to scarring, nutritional issues, or increased cancer risk in adulthood.

What is the life expectancy of someone with EB?

Life expectancy varies greatly depending on the type and severity of EB. People with mild forms can have normal life spans. However, severe forms, particularly severe junctional EB, can be life-threatening in infancy. Those with severe dystrophic EB may have life expectancies ranging from adolescence to 30 years, often due to complications such as infection, malnutrition, or aggressive skin cancer.

Are there any treatments or cures for EB?

Currently, there is no cure for epidermolysis bullosa. Treatment focuses on preventing blisters, caring for wounds when they occur, managing pain, preventing infection, and addressing nutritional needs. As of 2023, the FDA has approved the first gene therapy for treating wounds in dystrophic EB, and a topical gel containing birch bark extract for certain types of EB. Research into gene therapy and other advanced treatments continues.

🎯 Key takeaways

  • Epidermolysis bullosa is a rare genetic condition affecting about 1 in 50,000 babies, causing skin to blister and tear from the slightest friction or trauma.
  • There are four main types of EB—simplex, junctional, dystrophic, and Kindler syndrome—each affecting different layers of skin with varying severity.
  • EB is caused by mutations in at least 18 different genes that normally produce proteins essential for holding skin layers together.
  • The condition is inherited and cannot be spread through contact—it is not contagious in any way.
  • Symptoms range from localized blistering on hands and feet to widespread blistering affecting the entire body and internal organs like the mouth and esophagus.
  • People with severe forms of dystrophic EB face a dramatically increased risk of aggressive skin cancer at young ages, requiring vigilant monitoring.
  • Daily wound care for severe EB can take several hours and requires specialized bandages and supplies that may cost thousands of dollars monthly.
  • While there is currently no cure, recent FDA approvals of gene therapy and topical treatments offer new hope for managing symptoms and improving quality of life.